Financial statements Anapharma
Balance sheet of Anapharma
Company age:
Age:
8 y. 8 m. 13 d.
Share capital:
Share capital:
5 000 PLN
Balance sheet data of ANAPHARMA
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 499 502,58 | 409 010,00 | 392 310,60 | 352 721,26 | 553 286,47 | 606 854,77 |
| A. Fixed assets | 47 954,06 | 35 444,00 | 22 934,54 | 10 424,78 | 41 042,63 | 34 864,18 |
| B. Current assets | 451 548,52 | 373 566,00 | 369 376,06 | 342 296,48 | 512 243,84 | 571 990,59 |
| C. Share capital contributions (basic funds) | - | - | 0,00 | - | - | 0,00 |
| D. Own shares (stocks) | - | - | 0,00 | - | - | 0,00 |
| Total liabilities | 499 502,58 | 409 010,00 | 392 310,60 | 352 721,26 | 553 286,47 | 606 854,77 |
| A. Equity | 145 788,09 | 109 397,00 | 65 372,67 | 129 326,47 | 68 795,62 | 229 815,98 |
| B. Liabilities and provisions for liabilities | 353 714,49 | 299 613,00 | 326 937,93 | 223 394,79 | 484 490,85 | 377 038,79 |
| I. Long-term liabilities | - | - | 0,00 | 9 164,29 | 9 164,29 | 0,00 |
| II. Short-term liabilities | - | - | 326 937,93 | 214 230,50 | 475 326,56 | 377 038,79 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.